KSHB: New Cancer Treatment at Saint Luke’s Extends Kansas Woman’s Life Expectancy

In 2023, Alexis Ellington was diagnosed with stage 4 small cell lung cancer. Doctors gave her two to three months to live.

That was before she found Dr. Dhruv Bansal, director of precision and thoracic oncology at Saint Luke's Cancer Institute, in September of 2024. He introduced her to a new FDA-approved treatment called Bispecific T-cell Engagers therapy, or BiTE.

KSHB talked with Ellington and Dr. Bansal about this new treatment option that gave her renewed hope and is extending her time with loved ones.

Related Content

Jun. 28, 2024

FOX4: Saint Luke's North Hospital to Offer New Comprehensive Cancer Program
FOX4 talked to Dr. Tim Pluard about what will be included in the expansion and what it means for patients battling cancer in the Northland.
Nov. 24, 2023

Health News You Can Use: Precision Oncology for Lung Cancer
We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.
Nov. 23, 2022

Health News You Can Use: Lung Cancer Awareness
Today we are talking with Matthew Aboudara, MD, Interventional Pulmonologist & Member of the Lung Screening Task Force at Saint Luke’s Health System, about the importance of lung cancer screening, who is eligible, and what the screening entails.